| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031015741 |
| P356 | DOI | 10.1186/1471-2377-3-4 |
| P932 | PMC publication ID | 184375 |
| P698 | PubMed publication ID | 12848902 |
| P5875 | ResearchGate publication ID | 10672052 |
| P50 | author | John Anthony Hardy | Q6237755 |
| Bradford B Worrall | Q78887407 | ||
| James F Meschia | Q78887459 | ||
| Thomas G Brott | Q87844681 | ||
| Michael Frankel | Q88682792 | ||
| P2093 | author name string | Stephen S Rich | |
| Robert D Brown | |||
| José G Merino | |||
| Scott Silliman | |||
| Richard J P Crook | |||
| Ischemic Stroke Genetics Study | |||
| P2860 | cites work | Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment | Q22306370 |
| Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke | Q52864845 | ||
| Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage | Q52867277 | ||
| Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. | Q52868199 | ||
| Interrater reliability of an etiologic classification of ischemic stroke | Q52880414 | ||
| Privacy in genetics research | Q53541511 | ||
| Task force 3: clinical research in a molecular era and the need to expand its ethical imperatives | Q58674999 | ||
| The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators | Q68250496 | ||
| Reliability of the activities of daily living scale and its use in telephone interview | Q69416075 | ||
| Interobserver agreement for the assessment of handicap in stroke patients | Q69621777 | ||
| Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C | Q70878586 | ||
| Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea | Q71477377 | ||
| Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction | Q71575892 | ||
| Factor V Leiden mutation in cerebral venous thrombosis | Q71614843 | ||
| Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association | Q72157186 | ||
| Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study | Q72171512 | ||
| Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke | Q72294581 | ||
| Brief clinical report on a deletion 5q35.3. | Q72306583 | ||
| Genetic testing and insurance. The Ad Hoc Committee on Genetic Testing/Insurance Issues | Q72419255 | ||
| Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men | Q72596362 | ||
| PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis | Q73073912 | ||
| Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial | Q73230336 | ||
| Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study | Q73288997 | ||
| Polymorphisms of the Human Platelet Antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the Platelet Receptors for Fibrinogen (GPIIb/IIIa), von Willebrand Factor (GPIb/IX), and Collagen (GPIa/IIa) Are Not Correlated With an Increased Risk for Stroke | Q73520139 | ||
| Risk of Stroke in Young Women and Two Prothrombotic Mutations: Factor V Leiden and Prothrombin Gene Variant (G20210A) | Q74324113 | ||
| G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men | Q74529473 | ||
| The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients | Q77785414 | ||
| Subtyping in ischemic stroke genetic research | Q81370684 | ||
| Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease | Q95817885 | ||
| The Siblings With Ischemic Stroke Study (SWISS) protocol | Q24803218 | ||
| A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 | ||
| Classification and natural history of clinically identifiable subtypes of cerebral infarction | Q28244314 | ||
| Tissue plasminogen activator for acute ischemic stroke | Q29619377 | ||
| Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration | Q29619529 | ||
| Spouses and unrelated friends of probands as controls for stroke genetics studies | Q30310914 | ||
| Ethical and methodological issues in pedigree stroke research | Q30440503 | ||
| Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis | Q33744558 | ||
| Association studies of genetic polymorphisms and complex disease | Q33838028 | ||
| Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. | Q33883119 | ||
| Verifying the stroke-free phenotype by structured telephone interview | Q33910376 | ||
| Protecting the privacy of family members in survey and pedigree research | Q34140327 | ||
| Assessment of outcome after severe brain damage | Q34216702 | ||
| Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination | Q34392784 | ||
| A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. | Q34407258 | ||
| The Barthel ADL Index: a reliability study | Q34688100 | ||
| Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis | Q34784218 | ||
| Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research | Q35018261 | ||
| Genetic privacy: orthodoxy or oxymoron? | Q36687387 | ||
| Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators | Q40791071 | ||
| Beta-fibrinogen gene polymorphism (C148-->T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study | Q40865829 | ||
| Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment | Q40968365 | ||
| The problem of ignoring interconnectedness in genetic research | Q43077795 | ||
| Genetic polymorphisms of factor VII are not associated with arterial thrombosis | Q44057738 | ||
| Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke Study | Q46455250 | ||
| Planning genetic studies and human stroke: sample size estimates based on family history data | Q47176159 | ||
| Naming Names in Human Genetic Variation Research | Q47750911 | ||
| Platelet GP IIIa Pl A and GP Ib Variable Number Tandem Repeat Polymorphisms and Markers of Platelet Activation in Acute Stroke | Q47810129 | ||
| Rules for research on human genetic variation--lessons from Iceland | Q47852953 | ||
| The Icelandic Healthcare Database and informed consent | Q47852963 | ||
| Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation | Q48217375 | ||
| The Apolipoprotein E ε4 Allele and Outcome in Cerebrovascular Disease | Q48398522 | ||
| PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism | Q48554435 | ||
| The Apolipoprotein E and β-Fibrinogen G/A-455 Gene Polymorphisms Are Associated With Ischemic Stroke Involving Large-Vessel Disease | Q48577057 | ||
| APC resistance and factor V Leiden (FV:Q506) mutation in patients with ischemic cerebral events. Vienna Thrombophilia in Stroke Study Group (VITISS) | Q48603448 | ||
| The transition G to A at position 20210 in the 3'-untranslated region of the prothrombin gene is not associated with cerebral ischemia. | Q48604490 | ||
| Factor V Leiden mutation and completed stroke | Q49105004 | ||
| Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls | Q50628979 | ||
| Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. | Q50863506 | ||
| Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease | Q50962201 | ||
| Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality | Q50962675 | ||
| Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. | Q51026891 | ||
| Apolipoprotein E polymorphism in cerebrovascular disease. | Q52863953 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4 | |
| P577 | publication date | 2003-07-08 | |
| P1433 | published in | BMC Neurology | Q15763734 |
| P1476 | title | The Ischemic Stroke Genetics Study (ISGS) Protocol | |
| P478 | volume | 3 |
| Q28943330 | A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release |
| Q30440379 | Association of integrin alpha2 gene variants with ischemic stroke |
| Q33834878 | Bio-Repository of DNA in stroke (BRAINS): a study protocol |
| Q24649888 | Candidate gene polymorphisms for ischemic stroke |
| Q30428008 | Common mitochondrial sequence variants in ischemic stroke |
| Q30414654 | Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage |
| Q30430617 | Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials |
| Q30440498 | Family history of stroke and severity of neurologic deficit after stroke |
| Q37012822 | Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke |
| Q36018306 | Genetics of cerebrovascular disorders |
| Q30410548 | Genome-wide analysis of blood pressure variability and ischemic stroke |
| Q30430623 | Genomic risk profiling of ischemic stroke: results of an international genome-wide association meta-analysis |
| Q30440385 | IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations |
| Q30445563 | Impact of restricting enrollment in stroke genetics research to adults able to provide informed consent |
| Q48203208 | In search of genes for stroke |
| Q56999326 | Integrative Analysis of Transcriptomics and Proteomics Data for the Characterization of Brain Tissue After Ischemic Stroke |
| Q30279161 | Meta-Analysis of Genome-Wide Association Studies Identifies Genetic Risk Factors for Stroke in African Americans |
| Q36418529 | Multilingual Validation of the Questionnaire for Verifying Stroke-Free Status in West Africa |
| Q44772240 | NINDS Stroke Genetics Network (SiGN) Experience with the Causative Classification System |
| Q80482533 | Not so accidental outcomes following cerebrovascular accidents |
| Q30445412 | Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke |
| Q37728756 | Polymorphisms of genes in nitric oxide-forming pathway associated with ischemic stroke in Chinese Han population |
| Q30438233 | Prestroke physical activity and early functional status after stroke |
| Q34544496 | Principal-component analysis for assessment of population stratification in mitochondrial medical genetics |
| Q30440487 | Sex differences in stroke evaluations in the Ischemic Stroke Genetics Study |
| Q30444521 | Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke |
| Q30438901 | Structural genomic variation in ischemic stroke |
| Q36952445 | TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease |
| Q36984487 | Using family members to augment genetic case-control studies of a life-threatening disease |
| Q36854881 | Validation of the 8-item questionnaire for verifying stroke free status with and without pictograms in three West African languages |
| Q30429797 | White matter hyperintensity volume is increased in small vessel stroke subtypes |
| Q37599387 | Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. |
| Q37344135 | Whole genome approaches in ischemic stroke |
Search more.